2,4,5-三乙氧基苯甲醛 | 67827-54-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 2,4,5-三乙氧基苯甲醛
• 英文名称: 2,4,5-triethoxy-benzaldehyde
• 英文别名: 2,4,5-Triaethoxy-benzaldehyd；2,4,5-triethoxybenzaldehyde；2.4.5-Triethoxy-benzaldehyd
• CAS: 67827-54-7
• 化学式: C₁₃H₁₈O₄
• 分子量: 238.284
• InChiKey: OQEPUQXAJPNVFJ-UHFFFAOYSA-N

物化性质

• 沸点：
  373.2±37.0 °C(Predicted)
• 密度：
  1.070±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  17
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 海关编码：
  2912499000

反应信息

• 作为反应物：
  描述：

  2,4,5-三乙氧基苯甲醛 在 溴 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 生成 1,2,4-Triazolo(3,4-a)phthalazine, 6-ethoxy-3-(2,4,5-triethoxyphenyl)-
  参考文献：
  名称：

  Tarzia; Occelli; Corsico, Farmaco, Edizione Scientifica, 1988, vol. 43, # 2, p. 189 - 201

  摘要：

  DOI：
• 作为产物：
  描述：

  1,2,4-苯三酚 在 potassium carbonate 、 丙酮 、 三氯氧磷 作用下， 生成 2,4,5-三乙氧基苯甲醛
  参考文献：
  名称：

  Govindachari et al., Journal of the Chemical Society, 1957, p. 545

  摘要：

  DOI：

文献信息

• 6-(Alkylamino)-3-aryl-1,2,4-triazolo[3,4-a]phthalazines. A new class of benzodiazepine receptor ligands
  作者：Giorgio Tarzia、Emilio Occelli、Emilio Toja、Domenico Barone、Nerina Corsico、Licia Gallico、Franco Luzzani

  DOI：10.1021/jm00401a010

  日期：1988.6

  Some 6-(alkylamino)-3-aryl-1,2,4-triazolo[3,4-a]phthalazines have been shown to displace diazepam from rat brain specific binding sites, in vitro, with Ki (nM) values comparable to those of reference benzodiazepines and to have anticonvulsant (pentylenetetrazole test, mice) and anticonflict activity (Vogel test, rat) in vivo. Separation between the doses causing anticonflict effects (Vogel test, rat)

  研究表明，一些6-（烷基氨基）-3-芳基-1,2,4-三唑并[3,4-a]酞嗪在体外能从大鼠脑特异性结合位点置换地西epa，Ki（nM）值可与在体内具有抗惊厥药（戊四氮试验，小鼠）和抗冲突活性（Vogel试验，大鼠）。对于N，N-双（2-甲氧基乙基）-3-（4-甲氧基苯基）-1,2，已经证明了引起抗冲突作用的剂量（Vogel试验，大鼠）和损害运动协调的剂量（rotarod试验，大鼠）之间的隔离，4-三唑并[3，4-a]酞嗪6-胺（80）。与地西epa不同，该化合物在对抗士的宁（小鼠）和最大的电击（小鼠）引起的惊厥和“攻击性猴子”模型中无效。
• Compositions containing aromatic aldehydes and their use in treatments
  申请人：——

  公开号：US20030124157A1

  公开（公告）日：2003-07-03

  Disclosed are pharmaceutical and cosmetic compositions containing aromatic aldehyde compounds. Some of the disclosed compositions are useful as topical therapeutics for treating inflammatory dermatologic conditions. Some of the compositions are useful in transdermal and other systemic dose forms for treating other inflammatory conditions in mammals.

  揭示了含有芳香醛类化合物的药用和化妆品组合物。其中一些组合物可用作治疗炎症性皮肤病的局部治疗药物。其中一些组合物可用于治疗哺乳动物体内其他炎症性疾病的经皮和其他系统剂型。
• COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR
  申请人：HUMAN BIOMOLECULAR RESEARCH INSTITUTE

  公开号：US20160038641A1

  公开（公告）日：2016-02-11

  Compositions of small molecules, matrices, and isolated cells including methods of preparation, and methods for differentiation, transdifferentiation, and proliferation of animal cells into the osteoblast blast cell lineage were described. Examples of osteogenic materials that were administered to cells or co-cultured with cells are represented by compounds of Formula II, IV, and VI independently or preferably in combination with a matrix to afford bone cells. Small molecule-stimulated cells were also combined with a matrix, placed with a cellular adhesive or material carrier and implanted to a site in an animal for bone repair. Matrix pretreated with compounds of Formula II, IV, and VI were also used to cause cells to migrate to the matrix that is of use for therapeutic purposes.

  描述了由小分子、基质和孤立细胞组成的组合物，包括制备方法，以及动物细胞分化、转分化和增殖成骨母细胞谱系的方法。给细胞施加的或与细胞共培养的成骨材料的示例由独立或首选与基质组合的Formula II、IV和VI化合物代表。受小分子刺激的细胞还与基质结合，与细胞粘合剂或材料载体一起植入到动物体内的部位进行骨修复。预先用Formula II、IV和VI化合物处理的基质也被用于导致细胞迁移到用于治疗目的的基质上。
• Synthetic analogues of wedelolactone
  作者：T.R. Govindachari、K. Nagarajan、P.C. Parthasarathy

  DOI：10.1016/0040-4020(61)80016-1

  日期：1961.1

  The syntheses of 7′-methoxy- and 5′,7′,6-trimethoxy-coumarino(3′,4′:3,2)coumarones (IIa and IIb) are described.

  描述了7'-甲氧基-和5'，7'，6-三甲氧基-香豆素（3'，4'：3,2）香豆酮（IIa和IIb）的合成。
• Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
  申请人：Amgen Inc.

  公开号：US20030096819A1

  公开（公告）日：2003-05-22

  The present invention comprises a new class of novel aryl and heteroaryl substituted fused pyrrole compounds useful for the prophylaxis and treatment of diseases or conditions, such as TNF-&agr;, IL-1&bgr; , IL-6 and/or IL-8 mediated diseases, and other maladies, such as pain and diabetes. In particular, the compounds of the invention are useful for the prophylaxis and treatment of diseases or conditions involving inflammation. Accordingly, the invention also comprises pharmaceutical compositions comprising the compounds of the invention, methods for the prophylaxis and treatment of inflammation and other maladies, such as pain and diabetes, using the compounds and compositions of the invention, and intermediates and processes useful for the preparation of compounds of the invention. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  本发明涉及一类新型的芳基和杂环芳基取代融合吡咯化合物，用于预防和治疗疾病或病症，例如TNF-α，IL-1β，IL-6和/或IL-8介导的疾病，以及其他疾病，如疼痛和糖尿病。特别地，本发明的化合物用于预防和治疗涉及炎症的疾病或病症。因此，本发明还包括包含本发明的化合物的制药组合物，使用本发明的化合物和组合物预防和治疗炎症和其他疾病或病症的方法，以及用于制备本发明化合物的中间体和过程。本发明还涉及制备这种化合物的过程以及在这些过程中有用的中间体。